First Time Loading...

Walgreens Boots Alliance Inc
NASDAQ:WBA

Watchlist Manager
Walgreens Boots Alliance Inc Logo
Walgreens Boots Alliance Inc
NASDAQ:WBA
Watchlist
Price: 17.915 USD 1.79%
Updated: Apr 26, 2024
Section:
 

Wall Street
Price Targets

WBA Price Targets Summary
Walgreens Boots Alliance Inc

Wall Street analysts forecast WBA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for WBA is 23.162 USD with a low forecast of 18.18 USD and a high forecast of 36.75 USD.

WBA Lowest Forecast
Wall Street Target
18.18 USD
1% Upside
WBA Average Forecast
Wall Street Target
23.162 USD
29% Upside
WBA Highest Forecast
Wall Street Target
36.75 USD
105% Upside
Lowest
Price Target
18.18 USD
1% Upside
Average
Price Target
23.162 USD
29% Upside
Highest
Price Target
36.75 USD
105% Upside

WBA Last Price Targets
Walgreens Boots Alliance Inc

The latest public price target was made on Apr 15, 2024 by David MacDonald from Truist Financial , who expects WBA stock to rise by 12% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
David MacDonald
Truist Financial
20 USD
Upside 12%
1 week ago
Apr 15, 2024
Walgreens Boosts Alliance (WBA) PT Lowered to $20 at Truist Securities
StreetInsider
Charles Rhyee
Industrial Alliance Securities
35 USD
Upside 95%
3 weeks ago
Apr 2, 2024
Walgreens Boosts Alliance (WBA) PT Lowered to $35 at TD Cowen
StreetInsider
Erin Wright
Morgan Stanley
20 USD
Upside 12%
3 weeks ago
Apr 1, 2024
Walgreens Boosts Alliance (WBA) PT Lowered to $20 at Morgan Stanley, 'debate remains around visibility on the turnaround'
StreetInsider
Brian Tanquilut
Jefferies
19 USD
Upside 6%
4 weeks ago
Mar 29, 2024
Walgreens Boosts Alliance (WBA) PT Lowered to $19 at Jefferies
StreetInsider
Allen Lutz
Industrial Alliance Securities
22 USD
Upside 23%
1 month ago
Mar 26, 2024
Walgreens Boosts Alliance (WBA) PT Lowered to $22 at BofA Securities
StreetInsider
Steve Valiquette
Industrial Alliance Securities
21 USD
Upside 17%
1 month ago
Mar 20, 2024
Barclays Reiterates Underweight Rating on Walgreens Boosts Alliance (WBA)
StreetInsider
Charles Rhyee
Industrial Alliance Securities
37 USD
Upside 107%
1 month ago
Mar 14, 2024
TD Cowen Reiterates Outperform Rating on Walgreens Boosts Alliance (WBA)
StreetInsider
Adam Spielman
Citigroup
47 USD
Upside 162%
7 months ago
Sep 22, 2023
Wall Street's Most Accurate Analysts Say Hold These 3 Risk Off Stocks Delivering High-Dividend Yields
Benzinga
Ann Hynes
Mizuho Securities
31 USD
Upside 73%
9 months ago
Jul 24, 2023
Wall Street's Most Accurate Analysts Say Hold These 3 Risk Off Stocks Delivering High-Dividend Yields
Benzinga
Jonathan Yong
Credit Suisse
32 USD
Upside 79%
9 months ago
Jun 28, 2023
Walgreens Analysts Slash Their Forecasts After Q3 Results
Benzinga
Kevin Caliendo
UBS
37 USD
Upside 107%
10 months ago
Jun 5, 2023
Wall Street's Most Accurate Analysts Say Hold These 3 Defensive Stocks With Over 6% Dividend Yields
Benzinga
Erin Wright
Morgan Stanley
37 USD
Upside 107%
1 year ago
Mar 7, 2023
Check Out 3 High-Yielding Dividend Stocks In Defensive Sector From Wall Street's Most Accurate Analysts
Benzinga
Show More Price Targets
Show Less Price Targets
David MacDonald
Truist Financial
Price Target 20 USD
Upside/Downside 12%
View Source
Charles Rhyee
Industrial Alliance Securities
Price Target 35 USD
Upside/Downside 95%
View Source
Erin Wright
Morgan Stanley
Price Target 20 USD
Upside/Downside 12%
View Source
Brian Tanquilut
Jefferies
Price Target 19 USD
Upside/Downside 6%
View Source
Allen Lutz
Industrial Alliance Securities
Price Target 22 USD
Upside/Downside 23%
View Source
Steve Valiquette
Industrial Alliance Securities
Price Target 21 USD
Upside/Downside 17%
View Source
Charles Rhyee
Industrial Alliance Securities
Price Target 37 USD
Upside/Downside 107%
View Source
Adam Spielman
Citigroup
Price Target 47 USD
Upside/Downside 162%
View Source
Ann Hynes
Mizuho Securities
Price Target 31 USD
Upside/Downside 73%
View Source
Jonathan Yong
Credit Suisse
Price Target 32 USD
Upside/Downside 79%
View Source
Kevin Caliendo
UBS
Price Target 37 USD
Upside/Downside 107%
View Source
Erin Wright
Morgan Stanley
Price Target 37 USD
Upside/Downside 107%
View Source
Show More Price Targets
Show Less Price Targets
Walgreens Boots Alliance Inc Competitors:
Price Targets
9989
Sundrug Co Ltd
11% Upside
9267
Genky DrugStores Co Ltd
34% Upside
PNVL3
Dimed SA Distribuidora de Medicamentos
63% Upside
3549
Kusuri No Aoki Holdings Co Ltd
27% Upside
9989
Sundrug Co Ltd
11% Upside
9267
Genky DrugStores Co Ltd
34% Upside
PNVL3
Dimed SA Distribuidora de Medicamentos
63% Upside
3549
Kusuri No Aoki Holdings Co Ltd
27% Upside
4164
Al Nahdi Medical Company SCJSC
20% Upside
3349
Cosmos Pharmaceutical Corp
19% Upside
3088
MatsukiyoCocokara & Co
45% Upside
H
HL
Healthlead PCL
11% Upside

Revenue
Forecast

Revenue Estimate
Walgreens Boots Alliance Inc

For the last 8 years the compound annual growth rate for Walgreens Boots Alliance Inc's revenue is 4%. The projected CAGR for the next 3 years is 4%.

4%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Walgreens Boots Alliance Inc

For the last 8 years the compound annual growth rate for Walgreens Boots Alliance Inc's operating income is -5%. The projected CAGR for the next 3 years is 8%.

-5%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-13%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Walgreens Boots Alliance Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

See Also

Summary
WBA intrinsic value, competitors valuation, and company profile.
DCF Valuation
WBA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
WBA stock valuation using valuation multiples.
Wall Street Estimates
WBA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
WBA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is WBA's stock price target?
Price Target
23.162 USD

According to Wall Street analysts, the average 1-year price target for WBA is 23.162 USD with a low forecast of 18.18 USD and a high forecast of 36.75 USD.

What is Walgreens Boots Alliance Inc's Revenue forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Walgreens Boots Alliance Inc's revenue is 4%. The projected CAGR for the next 3 years is 4%.

What is Walgreens Boots Alliance Inc's Operating Income forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for Walgreens Boots Alliance Inc's operating income is -5%. The projected CAGR for the next 3 years is 8%.

ALPHA SPREAD
Join more than 131,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.